BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2981431)

  • 1. Bovine leukemia virus long terminal repeat: a cell type-specific promoter.
    Derse D; Caradonna SJ; Casey JW
    Science; 1985 Jan; 227(4684):317-20. PubMed ID: 2981431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression.
    Derse D; Casey JW
    Science; 1986 Mar; 231(4744):1437-40. PubMed ID: 3006241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trans activation of the bovine leukemia virus long terminal repeat in BLV-infected cells.
    Rosen CA; Sodroski JG; Kettman R; Burny A; Haseltine WA
    Science; 1985 Jan; 227(4684):320-2. PubMed ID: 2981432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bovine leukemia virus X region encodes a trans-activator of its long terminal repeat.
    Katoh I; Yoshinaka Y; Sagata N; Ikawa Y
    Jpn J Cancer Res; 1987 Feb; 78(2):93-8. PubMed ID: 3030987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure of cloned 3'-terminal RNA region of bovine leukemia virus (BLV).
    Tsimanis A; Bichko V; Dreilina D; Meldrais J; Lozha V; Kukaine R; Gren E
    Nucleic Acids Res; 1983 Sep; 11(17):6079-87. PubMed ID: 6310526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleotide sequence and structure of integrated bovine leukemia virus long terminal repeats.
    Derse D; Diniak AJ; Casey JW; Deininger PL
    Virology; 1985 Feb; 141(1):162-6. PubMed ID: 2983496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine leukemia virus: unique structural features of its long terminal repeats and its evolutionary relationship to human T-cell leukemia virus.
    Sagata N; Yasunaga T; Ogawa Y; Tsuzuku-Kawamura J; Ikawa Y
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4741-5. PubMed ID: 6087346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive effect of liposomes containing DNA coding for diphtheria toxin A-chain on cells transformed with bovine leukemia virus.
    Kakidani H; Watarai S; Onuma M; Tomochika K; Yasuda T
    Microbiol Immunol; 1993; 37(9):713-20. PubMed ID: 8271974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone regulation of bovine leukemia virus via the long terminal repeat.
    Niermann GL; Buehring GC
    Virology; 1997 Dec; 239(2):249-58. PubMed ID: 9434716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the bovine leukaemia virus LTR U3 promoter for expressing antisense antiviral RNAs and competitive inhibition of viral infection in cell culture.
    Shayakhmetov D; Kovalenko D; Yurov G; Borisenko A; Tikchonenko T
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1941-8. PubMed ID: 9266992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlapping CRE and E box motifs in the enhancer sequences of the bovine leukemia virus 5' long terminal repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter: implications for viral latency.
    Calomme C; Dekoninck A; Nizet S; Adam E; Nguyên TL; Van Den Broeke A; Willems L; Kettmann R; Burny A; Van Lint C
    J Virol; 2004 Dec; 78(24):13848-64. PubMed ID: 15564493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of enhancer sequences in type II human T-cell leukemia virus and bovine leukemia virus long terminal repeats by virus-associated trans-acting regulatory factors.
    Rosen CA; Sodroski JG; Kettman R; Haseltine WA
    J Virol; 1986 Mar; 57(3):738-44. PubMed ID: 3005624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive luminescence syncytium induction assay (LuSIA) based on a reporter plasmid containing a mutation in the glucocorticoid response element in the long terminal repeat U3 region of bovine leukemia virus.
    Sato H; Watanuki S; Bai L; Borjigin L; Ishizaki H; Matsumoto Y; Hachiya Y; Sentsui H; Aida Y
    Virol J; 2019 May; 16(1):66. PubMed ID: 31109347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo protein binding and functional analysis of cis-acting elements in the U3 region of the bovine leukemia virus long terminal repeat.
    Xiao J; Buehring GC
    J Virol; 1998 Jul; 72(7):5994-6003. PubMed ID: 9621062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence polymorphisms in the long terminal repeat of bovine leukemia virus: evidence for selection pressures in regulatory sequences.
    Zhao X; Jimenez C; Sentsui H; Buehring GC
    Virus Res; 2007 Mar; 124(1-2):113-24. PubMed ID: 17123656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide sequence analysis of the long terminal repeat of integrated bovine leukemia provirus DNA and of adjacent viral and host sequences.
    Couez D; Deschamps J; Kettmann R; Stephens RM; Gilden RV; Burny A
    J Virol; 1984 Feb; 49(2):615-20. PubMed ID: 6319764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of long terminal repeat sequences of HTLV-III.
    Starcich B; Ratner L; Josephs SF; Okamoto T; Gallo RC; Wong-Staal F
    Science; 1985 Feb; 227(4686):538-40. PubMed ID: 2981438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine leukemia virus transcription is controlled by a virus-encoded trans-acting factor and by cis-acting response elements.
    Derse D
    J Virol; 1987 Aug; 61(8):2462-71. PubMed ID: 3037109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of U3 promotor from the LTR region of bovine leukemia virus for expressing genes for antiviral antisense RNAs in cell cultures].
    Borisenko AS; Shaiakhmetov DM; Gerzilova AG; Tikhonenko TI
    Mol Gen Mikrobiol Virusol; 1994; (3):16-20. PubMed ID: 8065378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine leukemia virus long terminal repeat variability: identification of single nucleotide polymorphisms in regulatory sequences.
    Pluta A; Rola-Łuszczak M; Douville RN; Kuźmak J
    Virol J; 2018 Oct; 15(1):165. PubMed ID: 30359262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.